Evidence map›Paper›PMID 26842480›Full record

ArticleJournal of virology2016

gD-Independent Superinfection Exclusion of Alphaherpesviruses.

A Criddle, T Thornburg, I Kochetkova, M DePartee, M P Taylor

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Virological and Immunological Outcomes of Coinfections.Clinical microbiology reviews · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

A CriddleDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USAUniversity of California, Irvine.
T ThornburgDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USAUniversity of California, Irvine.
I KochetkovaDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USAUniversity of California, Irvine.
M DeParteeDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USAUniversity of California, Irvine.
M P TaylorDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USAUniversity of California, Irvine mptaylor@montana.edu.ORCID http://orcid.org/0000-0003-0199-7175
Montana State University · US

Funding

Center for Zoonotic and Emerging Infectious DiseasesP20GM103500 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2012 to 2013
$4.2M
Understanding the bottleneck on axon-to-cell spread of alphaherpesvirusesK22AI106948 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI TAYLOR, MATTHEW P. · 2014 to 2015
$268k
Howard Hughes Medical Institute 52006931NIAID NIH HHS K22 AI106948NIGMS NIH HHS 8P20GM103500-10NIGMS NIH HHS P20 GM103500
6 · The paper itself

Abstract

unlabelledMany viruses have the capacity to prevent a cell from being infected by a second virus, often termed superinfection exclusion. Alphaherpesviruses, including the human pathogen herpes simplex virus 1 (HSV-1) and the animal herpesvirus pseudorabies virus (PRV), encode a membrane-bound glycoprotein, gD, that can interfere with subsequent virion entry. We sought to characterize the timing and mechanism of superinfection exclusion during HSV-1 and PRV infection. To this end, we utilized recombinant viruses expressing fluorescent protein (FP) markers of infection that allowed the visualization of viral infections by microscopy and flow cytometry as well as the differentiation of viral progeny. Our results demonstrated the majority of HSV-1- and PRV-infected cells establish superinfection exclusion by 2 h postinfection. The modification of viral infections by virion inactivation and phosphonoacetic acid, cycloheximide, and actinomycin D treatments indicated new protein synthesis is needed to establish superinfection exclusion. Primary infection with gene deletion PRV recombinants identified that new gD expression is not required to establish superinfection exclusion of a secondary viral inoculum. We also identified the timing of coinfection events during axon-to-cell spread, with most occurring within a 2-h window, suggesting a role for cellular superinfection exclusion during neuroinvasive spread of infection. In summary, we have characterized a gD-independent mechanism of superinfection exclusion established by two members of the alphaherpesvirus family and identified a potential role of exclusion during the pathogenic spread of infection. IMPORTANCE: Superinfection exclusion is a widely observed phenomenon initiated by a primary viral infection to prevent further viruses from infecting the same cell. The capacity for alphaherpesviruses to infect the same cell impacts rates of interviral recombination and disease. Interviral recombination allows genome diversification, facilitating the development of resistance to antiviral therapeutics and evasion of vaccine-mediated immune responses. Our results demonstrate superinfection exclusion occurs early, through a gD-independent process, and is important in the directed spread of infection. Identifying when and where in an infected host viral genomes are more likely to coinfect the same cell and generate viral recombinants will enhance the development of effective antiviral therapies and interventions.

Indexed as

AnimalsCell LineCells, CulturedChlorocebus aethiopsHerpesvirus 1, HumanHerpesvirus 1, SuidRatsReassortant VirusesSuperinfectionVero CellsViral Envelope ProteinsViral Envelope Proteins

Identifiers

PMID26842480
PMCPMC4810564
OpenAlexW2269582224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.